First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

被引：3
作者：
Nguyen, Geoffrey C. [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
GASTROENTEROLOGY | 2016年 / 151卷 / 01期
关键词：
NONMELANOMA SKIN-CANCER; COMBINATION THERAPY; RISK; AZATHIOPRINE; EPIDEMIOLOGY; INFLIXIMAB; AGENTS;
D O I：
10.1053/j.gastro.2016.05.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：22 / 24
页数：4
相关论文
共 50 条
  • [41] Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view
    Rodriguez-Lago, Iago
    Manuel Benitez, Jose
    Garcia-Sanchez, Valle
    Gutierrez, Ana
    Sempere, Laura
    Ginard, Daniel
    Barreiro-de Acosta, Manuel
    Luis Cabriada, Jose
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (07): : 423 - 431
  • [42] Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease
    Lutz, Megan
    Caldera, Freddy
    Schroeder, Katie
    Gazis, Derek
    Crawford, Julie M.
    Long, Millie D.
    Barnes, Edward L.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (11) : e00620
  • [43] COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
    Lichtenstein, Lev
    Koslowsky, Benjamin
    Ben Ya'acov, Ami
    Avni-Biron, Irit
    Ovadia, Baruch
    Ben-Bassat, Ofer
    Naftali, Timna
    Kopylov, Uri
    Haberman, Yael
    Eran, Hagar
    Eliakim, Rami
    Lahat-Zok, Adi
    Hirsch, Ayal
    Zittan, Eran
    Maharshak, Nitsan
    Waterman, Matti
    Israeli, Eran
    Goren, Idan
    Ollech, Jacob
    Yanai, Henit
    Ungar, Bella
    Avidan, Benjamin
    Ben Hur, Dana
    Melamud, Bernardo
    Segol, Ori
    Shalem, Zippora
    Dotan, Iris
    Odes, Selwyn
    Ben-Horin, Shomron
    Snir, Yf'at
    Milgrom, Yael
    Broide, Efrat
    Goldin, Eran
    Delgado, Shmuel
    Ron, Yulia
    Cohen, Nathaniel
    Maoz, Eran
    Zborovsky, Maya
    Odeh, Safwat
    Abu Freha, Naim
    Shachar, Eyal
    Chowers, Yehuda
    Engel, Tal
    Reiss-Mintz, Hila
    Segal, Arie
    Zinger, Adar
    Shitrit, Ariella Bar-Gil
    VACCINES, 2022, 10 (03)
  • [44] Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease
    Cohn, H. Matthew
    Dave, Maneesh
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (08) : 301 - 315
  • [45] Use of thiopurines in inflammatory bowel disease
    Frei, Pascal
    Biedermann, Luc
    Nielsen, Ole Haagen
    Rogler, Gerhard
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1040 - 1048
  • [46] Polysubstance use in inflammatory bowel disease
    Bogale, Kaleb
    Vrana, Kent
    Raup-Konsavage, Wesley
    Walter, Vonn
    Stuart, August
    Dalessio, Shannon
    Koltun, Walter
    Bernasko, Nana
    Tinsley, Andrew
    Williams, Emmanuelle
    Clarke, Kofi
    Coates, Matthew D.
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (12) : 706 - 713
  • [47] Infliximab: Use in inflammatory bowel disease
    Travassos W.J.
    Cheifetz A.S.
    Current Treatment Options in Gastroenterology, 2005, 8 (3) : 187 - 196
  • [48] A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
    Miehsler, W.
    Novacek, G.
    Wenzl, H.
    Vogelsang, H.
    Knoflach, P.
    Kaser, A.
    Dejaco, C.
    Petritsch, W.
    Kapitan, M.
    Maier, H.
    Graninger, W.
    Tilg, H.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (03) : 221 - 256
  • [49] Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection?
    Hans, Amneet K.
    Scott, Frank I.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1158 - 1159
  • [50] Previous Cancer/Lymphoma and Refractory Inflammatory Bowel Disease
    Bernheim, Oren
    Axelrad, Jordan
    Itzkowitz, Steven H.
    Colombel, Jean-Frederic
    DIGESTIVE DISEASES, 2015, 33 : 44 - 49
12345